P. Di Gennaro

Fructooligosaccharides-driven metabolism of a defined Lactobacillus probiotic consortium modulates hepatic lipid accumulation in a reductionist in vitro gut microbiota–liver interaction model

Introduction Metabolic dysfunction-associated steatotic liver disease may be influenced by human gut microbiota-derived metabolites. Fructooligosaccharides (FOS) and probiotic Lactobacillus species have been reported to be associated with metabolic improvements. However, the strain-specific contribution of defined prob...